| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/04/2013 | WO2013047677A1 Linear amplification method for trace dna fragment |
| 04/04/2013 | WO2013047428A1 Method for producing mature mast cell |
| 04/04/2013 | WO2013047372A1 Method for producing polypeptide fragment with high efficiency, which is suitable for ncl method |
| 04/04/2013 | WO2013047108A1 Test method employing level of soluble vascular endothelial proliferation factor receptor 1 as measure |
| 04/04/2013 | WO2013046960A1 Nucleic acid construct for use in screening for peptide antibody, and screening method using same |
| 04/04/2013 | WO2013046722A1 Ion concentration-dependent binding molecule library |
| 04/04/2013 | WO2013046205A1 Growth enhancement of plants |
| 04/04/2013 | WO2013046034A2 Use of non-subtype b gag proteins for lentiviral packaging |
| 04/04/2013 | WO2013045934A2 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
| 04/04/2013 | WO2013045916A1 Chimaeric surrogate light chains (slc) comprising human vpreb |
| 04/04/2013 | WO2013045652A1 Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries |
| 04/04/2013 | WO2013045639A1 LENTIVIRAL VECTORS PSEUDOTYPED WITH MUTANT BaEV GLYCOPROTEINS |
| 04/04/2013 | WO2013045632A1 Split inteins and uses thereof |
| 04/04/2013 | WO2013045616A1 Quartet breeding |
| 04/04/2013 | WO2013045510A1 Use of recombinant type iii "polyketide synthases" (pks iii) of marine brown algae |
| 04/04/2013 | WO2013045480A1 Chimeric nucleases for gene targeting |
| 04/04/2013 | WO2013045458A1 Stabilisation and isolation of extracellular nucleic acids |
| 04/04/2013 | WO2013045457A1 Stabilisation and isolation of extracellular nucleic acids |
| 04/04/2013 | WO2013045434A1 Methods for separating nucleic acids by size |
| 04/04/2013 | WO2013045432A1 Rapid method for isolating extracellular nucleic acids |
| 04/04/2013 | WO2013044867A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| 04/04/2013 | WO2013044859A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/04/2013 | WO2013044840A1 Neutralizing molecule of highly pathogenic avian influenza and preparation method therefor |
| 04/04/2013 | WO2013044792A1 Nicotinamide adenine dinucleotide gene encoding fluorescent probe, preparation method therefor and application thereof |
| 04/04/2013 | WO2013044742A1 Spl16 compositions and methods to increase agronomic performance of plants |
| 04/04/2013 | WO2013044575A1 Elisa kit for detecting polypeptide marker antigen |
| 04/04/2013 | WO2013044390A1 Increasing virus-like particle yield in plants |
| 04/04/2013 | WO2013044336A1 Oligonucleotides, use, method and kit for detecting the contamination of samples by yeasts |
| 04/04/2013 | WO2013023015A3 Targets for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes |
| 04/04/2013 | WO2013022203A9 Method for detecting nucleic acid using intercalator-conjugated metal nanoparticles |
| 04/04/2013 | WO2013021389A8 Downregulation of mir-7 for promotion of beta cell differentiation and insulin production |
| 04/04/2013 | WO2013014294A3 Improved baculovirus expression systems |
| 04/04/2013 | WO2013010998A3 Compositions and methods for immunomodulation |
| 04/04/2013 | WO2013010225A8 Enzymes for degrading organophosphates |
| 04/04/2013 | WO2013009967A3 Identifying affinity-matured human antibodies |
| 04/04/2013 | WO2013006263A3 Constitutively active aba receptor mutants |
| 04/04/2013 | WO2013005603A9 Agent for prevention and/or treatment of allergic inflammation in conjunctiva |
| 04/04/2013 | WO2012178101A3 Compositions and methods to remove genetic markers using counter-selection |
| 04/04/2013 | WO2012172277A4 Simian adenovirus and hybrid adenoviral vectors |
| 04/04/2013 | WO2012169940A3 Recombinant dna elements for the expression of recombinant proteins in insects |
| 04/04/2013 | WO2012168493A8 Recombinant dna elements for the expression of recombinant proteins in insects |
| 04/04/2013 | WO2012162514A3 Epigenetic co-repressors of the gamma-globin gene and methods of using same |
| 04/04/2013 | WO2012142313A3 Micro-rna inhibitors and their uses in disease |
| 04/04/2013 | WO2012114231A3 Method for producing recombinant enzymes capable of hydrolysing chlorophyll a chlorophyll derivative |
| 04/04/2013 | WO2012112156A3 Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof |
| 04/04/2013 | WO2012103522A3 Materials and methods for identifying patients susceptible to developing taxane induced neuropthy |
| 04/04/2013 | US20130086712 Nitrogen responsiveness in plants through the expression of pathways for the formation and catabolism of novel n-rich compounds |
| 04/04/2013 | US20130086711 Celery cultivar ads-24 |
| 04/04/2013 | US20130086710 New tomato variety NUN 00175 TOP |
| 04/04/2013 | US20130086709 Free branching poinsettia |
| 04/04/2013 | US20130086707 Alfalfa Variety 06N02PX |
| 04/04/2013 | US20130086706 Alfalfa Variety 05N16PY |
| 04/04/2013 | US20130086704 Pharmaceutical composition utilizing pancreatic beta cell proliferation factor |
| 04/04/2013 | US20130086701 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 04/04/2013 | US20130085262 Novel surface antigen |
| 04/04/2013 | US20130085259 Method and carrier complexes for delivering molecules to cells |
| 04/04/2013 | US20130085173 Supercoiled minicircle dna for gene therapy applications |
| 04/04/2013 | US20130085139 Oligomers |
| 04/04/2013 | US20130085112 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1 |
| 04/04/2013 | US20130085096 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/04/2013 | US20130085095 Protein complementation regulators |
| 04/04/2013 | US20130084641 Compositions and Methods for Protein Production |
| 04/04/2013 | US20130084621 Plasmid vector |
| 04/04/2013 | US20130084617 Transformed cells that ferment-pentose sugars and methods of their use |
| 04/04/2013 | US20130084612 Recombinant escherichia coli producing d-xylonic acid from d-xylose and method for producing d-xylonic acid using the same |
| 04/04/2013 | US20130084611 Novel Plant Acyltransferases Specific for Long-Chained, Multiply Unsaturated Fatty Acids |
| 04/04/2013 | US20130084608 Fungal proteases |
| 04/04/2013 | US20130084605 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase |
| 04/04/2013 | US20130084604 Method for improved protein production in filamentous fungi |
| 04/04/2013 | US20130084602 Soluble expression of bulky folded active proteins |
| 04/04/2013 | US20130084600 Native nad-dependent gapdh replaced with nadp-dependent gapdh plus nadk |
| 04/04/2013 | US20130084596 Methods of identifying lead compounds that modulate toxicity of neurotoxic polypeptides |
| 04/04/2013 | US20130084581 Method of Identifying Transmembrane Protein-Interacting Compounds |
| 04/04/2013 | US20130084569 Nanomotors and motion-based detection of biomolecular interactions |
| 04/04/2013 | US20130084331 Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084296 Modulation of srpx2-mediated angiogenesis |
| 04/04/2013 | US20130084295 Anti-interferon-alpha antibodies |
| 04/04/2013 | US20130084290 Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof |
| 04/04/2013 | CA2850720A1 Binding molecule having influenza a virus-neutralizing activity produced from human b cell |
| 04/04/2013 | CA2850603A1 Compositions and methods for modulating hemostasis |
| 04/04/2013 | CA2850411A1 Split inteins and uses thereof |
| 04/04/2013 | CA2850407A1 Increasing virus-like particle yield in plants |
| 04/04/2013 | CA2850346A1 Ngf aptamer and application thereof |
| 04/04/2013 | CA2850322A1 Antigen-binding molecule inducing immune response to target antigen |
| 04/04/2013 | CA2850258A1 Inhibition of microrna-134 for the treatment of seizure-related disorders and neurologic injuries |
| 04/04/2013 | CA2850194A1 Antigen-binding molecule for promoting loss of antigens |
| 04/04/2013 | CA2850095A1 Biological methods for preparing adipic acid |
| 04/04/2013 | CA2850070A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| 04/04/2013 | CA2850041A1 Ion concentration-dependent binding molecule library |
| 04/04/2013 | CA2849765A1 Hybrid constant regions |
| 04/04/2013 | CA2849752A1 Method for producing polypeptide fragment with high efficiency, which is suitable for ncl method |
| 04/04/2013 | CA2849652A1 Use of non-subtype b gag proteins for lentiviral packaging |
| 04/04/2013 | CA2849476A1 Di-aliphatic substituted pegylated lipids |
| 04/04/2013 | CA2849471A1 Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
| 04/04/2013 | CA2849470A1 Ho/ll canola with resistance to clubroot disease |
| 04/04/2013 | CA2849354A1 Stabilisation and isolation of extracellular nucleic acids |
| 04/04/2013 | CA2849045A1 Lentiviral vectors pseudotyped with mutant baev glycoproteins |
| 04/04/2013 | CA2847924A1 Quartet breeding |
| 04/04/2013 | CA2847826A1 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |